Use of Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France: a Mixed-methods Study
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- University Hospital, Limoges
- Enrollment
- 85
- Locations
- 2
- Primary Endpoint
- Proportion of Complementary and alternative Medicine (CAM) use
Overview
Brief Summary
Integrative medicine promotes the incorporation of elements from complementary and alternative medicines (CAM) into patient care. These approaches are defined as treatments that are not routinely part of conventional medical care (1). CAM practices include osteopathy, acupuncture, aromatherapy, naturopathy, and various energy-based techniques, although their efficacy is not always well-established. Nevertheless, a meta-analysis on the use of CAM in the context of cancer reported a 40% prevalence of use in 2012 (2). Subsequently, a study conducted in France in 2015 revealed an 83% prevalence of CAM use across all types of cancer, underscoring the interest in these therapies (3). CAM is often employed to alleviate side effects of conventional treatments, such as fatigue, nausea, and vomiting. The 2015 French study primarily focused on solid tumors, with hematological malignancies representing only 2% of the cases, thereby limiting the assessment of CAM use in this context (3). Currently, there is no specific data evaluating the use of CAM among patients with hematological malignancies in France.
Hematological malignancies, unlike solid tumors, are characterized by their diffuse nature, making their localization and treatment more challenging for patients to comprehend (4). Additionally, a qualitative study the investigators conducted on the spiritual needs of patients recently diagnosed with hematological malignancies identified CAM as an area of interest. Among the ten patients in the study, seven were using CAM and reported an improvement in their spiritual well-being, which is defined as the ability to integrate the meaning and purpose of life into their health experiences, through relationships with themselves, others, art, nature, or a higher entity. This aspect of CAM utilization was not explored in our previous study on the spiritual needs of patients, particularly in understanding their appeal and the motivations of patients to adopt them.
Therefore, it appears crucial to explore this practice, which is known to be common among healthcare providers. Understanding these complementary care pathways would enable their safety (e.g., avoiding or informing about potential drug interactions) and foster the patient-provider relationship around a topic that is sometimes considered taboo (5). Ultimately, this would contribute to better supporting patients within a holistic care perspective.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients diagnosed with acute leukemia, lymphoma, or myeloma who are hospitalized and undergoing treatment at any of the study centers, regardless of the stage of the disease.
- •Patients aged 18 years or older.
- •Patients who are literate in French.
- •Patients who have been informed about the study and have provided their consent to participate.
- •Patients covered by health insurance.
Exclusion Criteria
- •Patients with neurocognitive disorders or severe psychiatric conditions.
- •Patients in the terminal stage of the disease.
- •Patients under legal protection measures, such as guardianship or curatorship.
- •Patients participating in an interventional study on the effectiveness of CAM.
Arms & Interventions
Hematological malignancies (leukemia, lymphoma or myeloma)
Intervention: Questionnaire on Complementary and Alternative Medicines (CAM) (Other)
Outcomes
Primary Outcomes
Proportion of Complementary and alternative Medicine (CAM) use
Time Frame: At the end of the study, 18 months after the first inclusion
This will be determined by identifying patients who report engaging in any form of complementary and alternative medicine, as there is no specific questionnaire available to assess this prevalence
Secondary Outcomes
- Percentage of use for each identified CAM(At the end of the study, 18 months after the first inclusion)
- Themes identified in content analysis:(At the end of the study, 18 months after the first inclusion)
- Average specific quality of life score(At the end of the study, 18 months after the first inclusion)
- Average score from the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being (FACIT-Sp) questionnaire(At the end of the study, 18 months after the first inclusion)
- Results of multivariate logistic regression(At the end of the study, 18 months after the first inclusion)